M/s. Unrwa - Head Field Logistics O Pharmaceutical Import Profile — Israel (DGFT 2022–2026)

Name: M/s. Unrwa - Head Field Logistics O Pharmaceutical Import Records from India — 2 Products, $650.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s. Unrwa - Head Field Logistics O — Pharmaceutical Importer Profile (2026) | 2 Products, $650.0K Trade | TransData Nexus

M/s. Unrwa - Head Field Logistics O

Pharmaceutical Importer · Israel · Antibiotics Focus · $650.0K Total Trade · DGFT Verified

M/s. Unrwa - Head Field Logistics O is a pharmaceutical importer based in Israel with a total trade value of $650.0K across 2 products in 2 therapeutic categories. Based on 13 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M/s. Unrwa - Head Field Logistics O sources from 1 verified Indian supplier, with Medopharm accounting for 100.0% of imports.

M/s. Unrwa - Head Field Logistics O — Import Portfolio & Supplier Network

M/s. Unrwa - Head Field Logistics O import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/s. Unrwa - Head Field Logistics O?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Medopharm	$509.7K	15	100.0%

M/s. Unrwa - Head Field Logistics O sources from 1 verified Indian supplier across 10 distinct formulations. The sourcing is highly concentrated — Medopharm accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does M/s. Unrwa - Head Field Logistics O Import?

Formulation	Value	Ships
Amoxicillin and clavulanate potassium	$252.5K	6
Carbamazepine tablets BP 200MG (3339 x	$50.0K	1
Famotidine tablets USP 40MG (15285 x	$50.0K	1
Carbamazepine tablets BP 200MG (5177 x	$50.0K	1
Paracetamol tablets BP 500MG (3500 x	$29.6K	1
Folic acid tablets BP 5MG (6278 x 100	$25.5K	1
Methyldopa tablets BP 250MG (731 x 100	$22.7K	1
Amoxicillin oral suspension BP 250MG/5ML	$16.3K	1
Folic acid tablets BP 5MG (2200 x 100	$8.8K	1
Doxycycline tablets BP 100MG (224 x	$4.2K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Amoxicillin	Antibiotics	$350.0K	7	0.1%	9
2	Potassium	Nutritional Supplements	$300.0K	6	0.0%	11

M/s. Unrwa - Head Field Logistics O imports 2 pharmaceutical products across 2 categories into Israel totaling $650.0K.

M/s. Unrwa - Head Field Logistics O — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s. Unrwa - Head Field Logistics Office (Unrwa HFO) is a procurement and logistics entity operating within Israel, primarily engaged in the importation of pharmaceutical products. As part of the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), Unrwa HFO plays a pivotal role in managing the supply chain for medical supplies, ensuring that essential pharmaceuticals reach their intended destinations efficiently. The office is headquartered in Jerusalem, Israel, and functions as a critical component of UNRWA's operations in the region.

In the context of Israel's pharmaceutical distribution landscape, Unrwa HFO serves as a significant importer, facilitating the entry of various medical products into the country. Its operations are integral to the broader humanitarian efforts aimed at providing medical assistance to Palestinian refugees and other vulnerable populations. By managing the procurement and logistics of pharmaceutical goods, Unrwa HFO ensures a steady supply of necessary medications, contributing to the overall health and well-being of the communities it serves.

2Distribution Network

Unrwa HFO's distribution network is strategically designed to ensure the efficient delivery of pharmaceutical products across Israel and into the Palestinian territories. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the office's operations are known to encompass the receipt, storage, and distribution of medical supplies. This includes managing the complexities of customs clearance, liaising with port and shipping authorities, and ensuring compliance with regulatory requirements. The logistics framework is tailored to meet the unique challenges of delivering medical supplies to areas with varying levels of accessibility, ensuring that essential pharmaceuticals reach their destinations in a timely and secure manner.

3Industry Role

Within Israel's pharmaceutical supply chain, Unrwa HFO functions as a specialized importer and logistics intermediary. Its primary role involves the procurement and distribution of pharmaceutical products, particularly those intended for humanitarian aid. By sourcing medications from various suppliers, including international markets, Unrwa HFO ensures a diverse and reliable supply of pharmaceuticals. Its operations are closely aligned with the objectives of UNRWA, focusing on meeting the medical needs of Palestinian refugees and other underserved populations in the region. Through its intermediary role, Unrwa HFO contributes to the stability and resilience of the pharmaceutical supply chain, addressing both routine and emergency medical requirements.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s. Unrwa - Head Field Logistics O

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Unrwa HFO's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from a single supplier. This concentrated sourcing approach suggests a strategic partnership or long-term agreement with the supplier, potentially aimed at ensuring consistent quality and supply reliability. However, such dependency also introduces risks associated with supply chain disruptions, as any issues affecting the sole supplier could impact Unrwa HFO's ability to meet its distribution commitments. The stability of this relationship is crucial; therefore, Unrwa HFO likely engages in regular assessments and maintains contingency plans to mitigate potential risks. The concentration of imports from a single supplier underscores the importance of robust supplier relationship management and the need for strategic diversification to enhance supply chain resilience.

2Supply Chain Resilience

The resilience of Unrwa HFO's supply chain is closely tied to its sourcing practices and the diversity of its supplier base. Relying predominantly on a single supplier for pharmaceutical imports may limit the office's ability to adapt to supply chain disruptions. To bolster resilience, Unrwa HFO could consider diversifying its supplier network, incorporating multiple suppliers to mitigate risks associated with single-source dependency. Additionally, establishing relationships with backup suppliers and ensuring compliance with international Good Manufacturing Practices (GMP) standards are essential steps toward enhancing supply chain robustness. By proactively addressing these areas, Unrwa HFO can strengthen its capacity to maintain a steady and reliable supply of pharmaceuticals, even in the face of unforeseen challenges.

Importing Pharmaceuticals into Israel — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Israel

1Regulatory Authority & Framework

In Israel, the Ministry of Health (MoH) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The regulatory framework governing these activities is primarily outlined in the Pharmacists Ordinance and its associated regulations. These regulations stipulate the requirements for the registration of medical preparations, including new active pharmaceutical ingredients (APIs), generics, and biosimilars. The MoH's guidelines, such as Circular No. 08_2012, provide detailed procedures for the registration process, specifying the necessary documentation and data required for approval. This framework ensures that all pharmaceutical products entering the Israeli market meet established standards of quality, safety, and efficacy.

2Import Licensing & GMP

Import licensing in Israel is governed by the MoH, which requires that all pharmaceutical products be registered before they can be imported and marketed. The registration process involves submitting a comprehensive dossier that includes preclinical and clinical data, as well as relevant scientific publications. For generic products, bioequivalence studies are mandatory. The MoH recognizes GMP certificates from reputable regulatory agencies, such as the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and the World Health Organization (WHO). Pharmaceutical importers must obtain wholesale distribution authorization from the MoH, ensuring compliance with all regulatory requirements and maintaining the integrity of the supply chain.

M/s. Unrwa - Head Field Logistics O — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Unrwa HFO's focus on importing antibiotics and nutritional supplements aligns with the pressing medical needs of the populations it serves. Antibiotics are crucial for treating a wide range of infections, while nutritional supplements address deficiencies and support overall health. The demand for these products is driven by factors such as the prevalence of infectious diseases, malnutrition, and the need for preventive healthcare measures. By prioritizing these therapeutic areas, Unrwa HFO ensures that essential medical supplies are available to meet the health challenges faced by Palestinian refugees and other vulnerable groups in the region.

2Sourcing Profile

Unrwa HFO's sourcing strategy for generic drugs involves procuring finished pharmaceutical formulations from suppliers that adhere to international quality standards. The office's preference for finished formulations over raw active pharmaceutical ingredients (APIs) indicates a focus on ensuring product quality and compliance with regulatory requirements. India's pharmaceutical industry, known for its robust manufacturing capabilities and adherence to global GMP standards, fits well into Unrwa HFO's procurement strategy. By sourcing from India, Unrwa HFO can access a diverse range of high-quality pharmaceutical products at competitive prices, thereby enhancing the efficiency and effectiveness of its supply chain.

Market Positioning

Seller's Guide — How to Become a Supplier to M/s. Unrwa - Head Field Logistics O

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For Indian pharmaceutical exporters, there is a realistic opportunity to become alternative suppliers to Unrwa HFO. The office's concentrated sourcing pattern suggests potential for diversification, which could enhance supply chain resilience. Indian exporters can leverage this opportunity by offering high-quality, cost-effective pharmaceutical products that meet international standards. Establishing partnerships with Unrwa H

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — M/s. Unrwa - Head Field Logistics O

What products does M/s. Unrwa - Head Field Logistics O import from India?

M/s. Unrwa - Head Field Logistics O imports 2 pharmaceutical products across 2 categories. Top imports: Amoxicillin ($350.0K), Potassium ($300.0K).

Who supplies pharmaceuticals to M/s. Unrwa - Head Field Logistics O from India?

M/s. Unrwa - Head Field Logistics O sources from 1 verified Indian suppliers. The primary supplier is Medopharm (100.0% of imports, $509.7K).

What is M/s. Unrwa - Head Field Logistics O's total pharmaceutical import value?

M/s. Unrwa - Head Field Logistics O's total pharmaceutical import value from India is $650.0K, based on 13 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s. Unrwa - Head Field Logistics O focus on?

M/s. Unrwa - Head Field Logistics O imports across 2 categories. The largest: Antibiotics (53.8%), Nutritional Supplements (46.2%).

Get Full M/s. Unrwa - Head Field Logistics O Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.